Zacks Investment Research on MSN
Hims & Hers expands weight-management program to the United Kingdom
Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the ...
NEW YORK, Dec 10 (Reuters) - Online telehealth company Hims and Hers Health is launching its weight-loss membership and ...
Zacks Investment Research on MSN
Investors heavily search Hims & Hers Health, Inc. (HIMS): Here is what you need to know
Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...
Hims & Hers Health stock has seen its fair value estimate trimmed from about $46.00 to roughly $44.36 per share, even as analysts grow more optimistic about its long term revenue trajectory. Stronger ...
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates as a deeply technology-driven digital ...
Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. Read why HIMS stock is a ...
Hims and Hers first announced its expansion into Canada in early July, taking the opportunity as Danish pharmaceutical giant ...
Delving into the details, we found 53% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $373,316, and 7 were calls, valued ...
Investing.com -- Hims Hers Health Inc (NYSE:HIMS) stock fell 4.4% Wednesday after U.S. lawmakers introduced legislation that could significantly impact the company’s fastest-growing product category.
Shares of Hims & Hers are trending Thursday morning. The San Francisco-based telehealth company announced an international ...
In a strategic pivot, the company has launched its weight-loss program in the United Kingdom. There, Hims & Hers is offering legitimate, branded medications—Novo Nordisk's Wegovy and Eli Lilly's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results